Tekoälypäivä 2027 · Fri 12.3. · Oodi, Helsinki · in FinnishTekoälypäivä 2027 · 12.3.Read more

For AI developers

How we support AI developers

We work with AI developers across the full development lifecycle, together with clinical experts, from the definition of clinical need to market access in European healthcare. Across the founding team, AiXiliator brings experience spanning the full medical AI development lifecycle.

Five stages

Clinical need to market access

  1. Clinical need

    Where the need is real

    In-depth analysis of unmet clinical needs and real-world clinical workflows.

  2. Value

    What the solution is worth

    Assessment of potential clinical and economic value.

  3. Evidence

    Evidence that answers the question

    Clinical evidence strategy, including trial and validation-study design, retrospective work and real-world evidence.

  4. Regulation

    A defined regulatory route

    Planning for medical-device regulation, clinical evaluation, data protection, quality requirements and the EU AI Act.

  5. Market access

    Adoption in European care

    Strategic planning for commercialization and adoption in European healthcare.

How we work with you

Working with the team, not writing a report

We take part in product decisions, in discussions with clinical partners, and in the meetings where the regulatory and commercial pathway is decided.

Clinical

Physician-level judgement

All three founders remain active in clinical practice. They assess where the software helps, where it introduces risk, and what clinicians need before using it.

Evidence

Studies that stand up to review

The founding team has extensive experience designing and conducting prospective and retrospective studies, multicentre research, clinical trials and real-world evidence studies, as well as navigating ethics and regulatory research processes.

European

The European regulatory environment

We help medical AI developers understand and plan for the European regulatory environment, including medical-device regulation, clinical evaluation, data protection, quality requirements and the evolving requirements of the EU AI Act.

Engagements usually begin with a short assessment of clinical need, evidence position and regulatory readiness, followed by an agreed set of next steps.